Sotagliflozin is intended for Pharmaceuticals applications and is a Sodium-glucose cotransporter 1 and 2 (SGLT1/SGLT2) inhibitor. Sotagliflozin is used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus but can be used also to reduce the risk of cardiovascular death and heart failure in patients with high risk factors. All information about Sotagliflozin is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year